Although IL-33 mediates the pancreatic cancer-preventive effect of tropisetron in our studies, future studies are essential to elucidate the role of tropisetron in modulating the broader immune response and tumor microenvironment. The gene discussed is IL33; the disease is familial pancreatic carcinoma.